CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −62 | $1.98 | $123 | 15,136 |
| 2021-10-04 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −62 | $2.01 | $125 | 15,198 |
| 2021-09-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −61 | $1.81 | $110 | 15,260 |
| 2021-08-03 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −63 | $2.40 | $151 | 15,321 |
| 2021-07-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −154 | $3.70 | $570 | 15,384 |
| 2021-06-04 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −155 | $4.19 | $649 | 15,538 |
| 2021-05-04 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −191 | $4.13 | $789 | 15,693 |
| 2021-04-08 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −192 | $4.94 | $948 | 15,884 |
| 2021-03-03 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −192 | $5.46 | $1K | 16,076 |
| 2021-02-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −988 | $6.34 | $6K | 16,268 |
| 2021-02-01 | Mann Brenda VP of Research & Development | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-01-04 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −115 | $4.85 | $558 | 17,256 |
| 2020-12-07 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −91 | $3.76 | $342 | 17,371 |
| 2020-11-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −96 | $3.51 | $337 | 17,462 |
| 2020-10-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −98 | $3.88 | $380 | 17,558 |
| 2020-09-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −97 | $3.94 | $382 | 17,656 |
| 2020-08-04 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −92 | $4.11 | $378 | 17,753 |
| 2020-07-02 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −94 | $4.82 | $453 | 17,845 |
| 2020-06-03 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −94 | $5.11 | $480 | 17,939 |
| 2020-05-05 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −113 | $5.10 | $576 | 18,033 |
Page 1 of 2 · 27 trades